Tampax Lawsuit 2026: What Buyers Must Know Now

Procter & Gamble is facing multiple active federal lawsuits alleging its Tampax Pearl and Tampax Radiant tampons contain undisclosed lead, exposing users to daily amounts that plaintiffs say exceed California’s own safety threshold. The Tampax lawsuit isn’t a single case it’s now at least three separate federal class actions moving through courts in California, Ohio, and Illinois.

The stakes are real: Tampax is one of the best-selling tampon brands in the country, a 2024 university study first raised the underlying lead concerns across the tampon industry broadly, and a federal magistrate judge has already ordered P&G to the settlement table with full negotiating authority.

If you’re researching related litigation in the period-care industry, our coverage of the Cora tampons lawsuit landscape shows how this same 2024 research triggered very different outcomes depending on the brand.

One fact worth knowing: the lead levels cited in the lead case were measured in millionths of a gram as little as 0.243 micrograms per tampon yet plaintiffs argue that’s still enough to exceed California’s Proposition 65 daily exposure limit when used as directed.

Quick Facts

Detail	Information
Defendant	The Procter & Gamble Company
Lead Case	Barton v. The Procter & Gamble Company, No. 3:24-cv-01332 (S.D. Cal.)
Lead Plaintiffs	Allison Barton, Jana Moreno
Related Cases	Sanchez et al. v. P&G (S.D. Ohio, filed Nov. 19, 2025); Otkina et al. v. P&G (N.D. Ill., filed Jan. 28, 2026)
Core Allegation	Tampax Pearl and Tampax Radiant tampons contain undisclosed lead, marketed as safe despite exceeding California’s Prop 65 exposure threshold
Filing Date (earliest)	July 2024
Current Status	Active litigation; settlement talks ordered, no settlement reached, no claim form available

What Is the Tampax Lawsuit About?

The Tampax lawsuit centers on claims that Procter & Gamble sold Tampax Pearl and Tampax Radiant tampons without disclosing they contain measurable amounts of lead. Plaintiffs allege that independent laboratory testing found lead levels ranging from approximately 0.243 micrograms in Tampax Pearl Light tampons to about 0.787 micrograms in Tampax Pearl Ultra.

According to the complaint, that exposure exceeds 0.5 micrograms per day — the Maximum Allowable Dose Level (MADL) for lead under California’s Proposition 65 — when the products are used as intended. Plaintiffs argue P&G’s product labeling and marketing led consumers to believe the tampons were free of harmful heavy metals.

Key Takeaway: This is a labeling and disclosure lawsuit, not (at this stage) a personal-injury case — the claims center on what P&G allegedly didn’t tell consumers, not on proven physical harm to a specific plaintiff.

Class Action Lawsuit / Legal Status Overview

Case	Court	Filed	Status
Barton v. The Procter & Gamble Company (3:24-cv-01332)	S.D. California	July 2024	Active — furthest along; settlement talks ordered
Sanchez et al. v. P&G	S.D. Ohio	November 19, 2025	Active — early pleading stage, nine named plaintiffs
Otkina et al. v. P&G	N.D. Illinois	January 28, 2026	Active — seeks nationwide class excluding California residents

Key Takeaway: Barton is the case to watch — it’s the most procedurally advanced and the one where a court has already ordered the parties into formal settlement discussions.

Latest Update 2026

• March 10, 2025: Plaintiffs in the Barton case file a Second Amended Complaint.
• April 7, 2025: P&G moves to dismiss the amended complaint.
• August 8, 2025: The court grants the motion to dismiss in part and denies it in part, allowing the core lead-disclosure claims to proceed.
• August 22, 2025: P&G files its formal answer to the surviving claims.
• Late 2025: U.S. Magistrate Judge Steve B. Chu orders both sides into an early neutral evaluation of settlement, directing representatives with full settlement authority to attend, with a case management conference reportedly set for October 31, 2025.
• January 28, 2026: A third related case, Otkina et al. v. P&G, is filed in the Northern District of Illinois.
• As of May 2026: No settlement agreement has been reached or submitted for court approval, and no official claim form exists for any of the three cases. Legal industry observers reportedly do not expect a claims process to open before late 2026 or mid-2027, based on current court scheduling.

Key Takeaway: A judge ordering settlement talks is a meaningful sign of case progress, but it is not the same as a settlement — P&G has not agreed to pay anything, and no timeline for a resolution is confirmed.

Key Allegations Explained

The Tampax lawsuits raise several distinct legal theories, all built around the same core lead-disclosure claim:

• Unfair and unlawful business practices: Under California consumer protection law, plaintiffs allege P&G’s marketing practices around Tampax Pearl and Radiant were unfair and unlawful given the undisclosed lead content.
• Deceptive advertising: The complaints argue P&G’s packaging and marketing created a false impression of safety by omitting known or knowable heavy-metal content.
• Consumer Legal Remedies Act (CLRA) violations: A California statute allowing consumers to sue over unfair methods of competition and deceptive practices in consumer transactions.
• Breach of implied warranty and unjust enrichment: Raised in the newer Ohio and Illinois filings, these theories argue P&G was unjustly enriched by selling products that didn’t meet the safety standard consumers reasonably expected.

Key Takeaway: None of the three active cases currently allege a specific personal injury tied to lead exposure — they focus on the disclosure and marketing failure itself.

Health Risks: What the Underlying Science Actually Shows

The Tampax cases trace back to a 2024 study by researchers at Columbia University and UC Berkeley, which found measurable levels of lead and other heavy metals — including arsenic and cadmium — across multiple tampon brands, Tampax Pearl varieties among them. The study did not determine whether those metals leach out during use or get absorbed into the body; it simply confirmed their presence in the material tested.

That open question is exactly what triggered both the 2024 wave of lawsuits and a follow-up federal investigation. In July 2026, the FDA published its own bench-testing and toxicological risk assessment in the journal *Toxicological Sciences*, finding trace levels of 19 metals — including lead and arsenic — in tested tampon products, but concluding the exposure levels carried “negligible toxicological concern” and were too low to pose a health risk during normal use.

Key Takeaway: There’s a real tension between the ongoing litigation and the FDA’s own 2026 findings — plaintiffs argue California’s stricter Prop 65 standard was still violated, while the FDA’s broader risk assessment concluded the exposure levels aren’t harmful. Both can be true at once, since Prop 65’s MADL threshold and the FDA’s health-risk assessment use different legal and scientific standards.

Is Tampax Actually Dangerous? (Myth-Check)

Given the alarming framing in some coverage, it’s worth separating what’s proven from what’s alleged:

• What’s confirmed: Independent lab testing, per the plaintiffs’ complaint, detected measurable lead in specific Tampax Pearl products, in amounts the lawsuit says exceed California’s Prop 65 daily exposure threshold.
• What’s not confirmed: No court has ruled that Tampax products are unsafe for use, and the FDA’s July 2026 risk assessment specifically concluded that trace metal levels found across the tampon category, including likely in Tampax products, don’t rise to a meaningful health risk.
• What’s still disputed: Whether Prop 65’s stringent MADL standard is the right benchmark for tampon safety, and whether the specific lead amounts alleged actually enter the bloodstream during normal use, remain open, contested questions in the litigation.

Key Takeaway: The lawsuit’s premise is about disclosure and a specific regulatory threshold, not a proven, undisputed health emergency — treat “Tampax gives you lead poisoning” framing as an overstatement of what’s currently established.

Company Background: How the Issue Started

Tampax has been one of the dominant tampon brands in the U.S. for decades, currently owned and marketed by Procter & Gamble under its broader feminine care portfolio. The Tampax Pearl and Tampax Radiant lines specifically marketed as premium, comfort-focused products are the ones named in the lead litigation.

The underlying controversy began with the 2024 Columbia/Berkeley study, which was the first academic research to systematically test for heavy metals across a wide range of tampon brands and types — organic and non-organic, U.S. and international. That study didn’t single out Tampax, but its findings became the evidentiary basis multiple plaintiffs’ firms used to build product-specific lawsuits against major brands, including P&G.

Consumer Complaints and Regulatory Attention

• U.S. Senator Patty Murray formally requested the FDA examine the 2024 study’s findings, citing that women may use more than 7,400 tampons over a lifetime.
• The FDA’s resulting July 2026 study represents the most authoritative government-level data currently available on tampon metal content, and it applies to the broader product category rather than to Tampax specifically.
• No public settlement, recall, or regulatory enforcement action specific to Tampax lead content has been announced as of this writing.

Who Qualifies for the Tampax Lawsuit?

Because no class has been certified and no settlement has been reached in any of the three active cases, there is no confirmed eligibility criteria yet. Based on the complaints as filed, the cases are structured to potentially cover:

• Consumers who purchased Tampax Pearl and/or Tampax Radiant tampons within the applicable statute-of-limitations period for their state.
• The Barton case specifically centers on California consumers and California’s consumer protection statutes.
• The newer Otkina case in Illinois seeks to represent a nationwide class explicitly excluding California residents, likely to avoid overlapping with the Barton case’s California-specific claims.

Key Takeaway: If you purchased Tampax Pearl or Radiant products, you may eventually fall into one of these proposed classes — but “may eventually qualify” is different from having a claim you can file today, since none of these classes has been certified yet.

Settlement Amount and Payout Estimates

No settlement amount has been reached, proposed, or approved in any of the three Tampax lawsuits as of this writing. Any specific dollar figure — total fund size or estimated per-person payout — currently circulating online for this case is speculative and not supported by a public court filing.

For context on how a comparable heavy-metals labeling case might resolve, past consumer product settlements involving undisclosed contaminants have varied enormously based on total class size and the strength of injury evidence — but applying any of those figures to Tampax specifically would be guesswork at this stage.

How Payout Would Likely Be Calculated (If a Settlement Is Reached)

Should the Barton case or a related matter eventually settle, payout structures in comparable consumer class actions typically depend on:

• Total settlement fund size, which would be negotiated between P&G and plaintiffs’ counsel.
• Number of valid claims filed, since the total fund is generally divided among all class members who submit documentation.
• Proof of purchase, with claimants who can document specific Tampax Pearl or Radiant purchases typically eligible for a higher payout tier than those without receipts.
• Attorneys’ fees, which in comparable cases have historically consumed roughly 25% to 33% of the total settlement fund before consumer payouts are calculated.

Key Takeaway: These are general patterns from similar consumer class actions, not confirmed terms for this case — no such framework has been finalized or approved by any court in the Tampax litigation.

How to File a Claim (Not Yet Available)

There is currently no claim form to file for any Tampax lawsuit, because no settlement or class certification has occurred. If and when a settlement is reached, the typical process would likely involve:

1. Court preliminary approval of a negotiated settlement.

2. A formal notice period alerting eligible class members.

3. A claims administrator opening an official claim form, likely hosted on a dedicated settlement website.

4. A defined filing deadline for submitting claims with any required documentation.

5. Final court approval before payments are distributed.

Key Takeaway: Legal industry observers do not expect this process to begin before late 2026 at the earliest, and more likely mid-2027 based on current case scheduling — treat any site offering a “Tampax lawsuit claim form” today with significant skepticism.

Filing Deadline / Statute of Limitations

No consumer filing deadline currently applies, because no settlement or claims window has opened. Separately, individuals considering an independent legal claim related to Tampax products should be aware that state statutes of limitations for consumer protection and product liability claims vary and can affect how long they have to pursue an individual case — consulting an attorney directly is the only way to confirm your specific deadline.

Other Related Lawsuits and Broader Context

• LOLA (Manson v. ALYK Inc., No. 7:21-cv-05688, S.D.N.Y.): A separate, unrelated active lawsuit alleges LOLA tampons lack a protective coating, causing shedding and infection risk — a manufacturing-defect claim rather than a heavy-metals claim.
• Cora: No lawsuit has been filed against Cora, despite some confusion online conflating unrelated brands with the Tampax and LOLA litigation.
• The broader wave of heavy-metals litigation touching the tampon industry reflects the same underlying 2024 research that also prompted the FDA’s 2026 risk assessment — a pattern of scientific findings driving both regulatory review and private litigation simultaneously.

Frequently Asked Questions

What is the Tampax lawsuit about?

The Tampax lawsuit refers to at least three active federal class actions against Procter & Gamble alleging Tampax Pearl and Tampax Radiant tampons contain undisclosed lead. The lead case, Barton v. The Procter & Gamble Company (No. 3:24-cv-01332), alleges lead exposure exceeding California’s Proposition 65 safety threshold and claims P&G’s marketing misled consumers into believing the products were free of harmful heavy metals.

Who qualifies for the Tampax lawsuit?

No class has been certified in any of the three cases, so eligibility isn’t legally confirmed yet. Based on the complaints, the proposed classes would likely include consumers who purchased Tampax Pearl or Tampax Radiant products within the applicable limitations period, with the Barton case focused on California purchasers and the Otkina case seeking a nationwide class excluding California residents.

How much money could the Tampax lawsuit pay out?

No settlement amount has been reached or proposed in any of the three cases as of this writing, so there is no verified payout estimate. Any specific dollar figure circulating online for this lawsuit should be treated as speculation, since no court filing has confirmed a settlement fund size or per-person payout structure.

Is Tampax actually dangerous based on the lawsuit’s claims?

The lawsuit alleges specific Tampax Pearl products exceed California’s strict Prop 65 lead exposure threshold, based on independent lab testing cited in the complaint. However, the FDA’s own July 2026 toxicological risk assessment found trace metals across the broader tampon category but concluded the exposure levels don’t pose a meaningful health risk during normal use — meaning the litigation’s regulatory threshold claim and the FDA’s health-risk conclusion aren’t necessarily in direct conflict, but they do reflect different standards.

What is the filing deadline for the Tampax lawsuit?

There is currently no consumer filing deadline because no settlement or certified class exists yet for any of the three active cases. Legal industry observers do not expect a claims process to open before late 2026 at the earliest, with mid-2027 considered more likely based on current court scheduling in the lead Barton case.

What Tampax Users Should Do Now

The bottom line: real, active litigation exists against P&G over lead in Tampax Pearl and Radiant products, and a federal magistrate judge has already pushed both sides toward settlement talks — but no settlement, class certification, or claim form exists as of this writing.

If you’re a regular Tampax Pearl or Radiant user concerned about this litigation, the most useful thing you can do right now is document your purchase history, since proof of purchase is typically the biggest factor in payout tiers if a settlement is eventually reached.

Watch the Barton case specifically, since it’s the most procedurally advanced and the one currently in court-ordered settlement discussions — developments there are likely to shape how the Ohio and Illinois cases proceed as well.

Be skeptical of any website claiming you can file a Tampax lawsuit claim today. No legitimate settlement fund or claims administrator currently exists for this litigation, and legitimate case updates will always reference one of the three real case numbers cited in this article.

Sources

• [Tampax Class Action Lawsuit Alleges Tampons Contain Unhealthy Levels of Lead — AboutLawsuits.com](https://www.aboutlawsuits.com/tampax-class-action-lawsuit-tampons-unhealthy-levels-lead/)
• [Tampon Class Action Lawsuit Over Lead Contamination Cleared To Move Forward — AboutLawsuits.com](https://www.aboutlawsuits.com/tampon-class-action-lawsuit-lead-contamination-move-forward/)
• [Tampon Lawsuit Settlement Talks Ordered Over Lead Levels in Tampax Pearl Products — AboutLawsuits.com](https://www.aboutlawsuits.com/tampon-lawsuit-settlement-talks-lead-levels-tampax-pearl/)
• [P&G hit with another class action over alleged lead in Tampax Pearl tampons — Top Class Actions](https://topclassactions.com/lawsuit-settlements/lawsuit-news/pg-hit-with-another-class-action-over-alleged-lead-in-tampax-pearl-tampons/)
• [Procter & Gamble must face class action lawsuit over lead in tampons — Top Class Actions](https://topclassactions.com/lawsuit-settlements/lawsuit-news/procter-gamble-must-face-class-action-lawsuit-over-lead-in-tampons/)
• [P&G Hit With Suit Over Alleged Lead In Tampax — Law360](https://www.law360.com/articles/2433830/p-g-hit-with-suit-over-alleged-lead-in-tampax)
• [Barton v. The Procter & Gamble Company docket — CourtListener](https://www.courtlistener.com/docket/68994556/barton-v-the-procter-gamble-company/)
• [Settlement Talks Ordered in Federal Lead-Containing Tampon Class Action — HarrisMartin Publishing](https://www.harrismartin.com/publications/27/MDL/articles/71615/settlement-talks-ordered-in-federal-lead-containing-tampon-class-action/)
• [First study to measure toxic metals in tampons shows arsenic and lead — UC Berkeley Public Health](https://publichealth.berkeley.edu/articles/spotlight/research/first-study-to-measure-toxic-metals-in-tampons-shows-arsenic-and-lead)
• [FDA Finds Heavy Metals in Tampons, Says Levels Too Low for Health Risk — Bloomberg](https://www.bloomberg.com/news/articles/2026-07-06/heavy-metals-in-tampons-aren-t-cause-for-concern-regulators-say)